SurModics, Inc. (SRDX) Reports In-Line Q1 EPS; Reaffirms Outlook
Tweet
Share
E-mailGet Alerts SRDX Hot Sheet
Price: $42.98 --0%
Financial Fact:
Income (loss) from operations: 4.08M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Income (loss) from operations: 4.08M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
SurModics, Inc. (NASDAQ: SRDX) reported Q1 EPS of $0.11, in-line with the analyst estimate of $0.11. Revenue for the quarter came in at $11.9 million versus the consensus estimate of $12.21 million.
Reaffirms outlook.
For earnings history and earnings-related data on SurModics, Inc. (SRDX) click here.
Reaffirms outlook.
For earnings history and earnings-related data on SurModics, Inc. (SRDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- CoStar Group acquires Zonda for $800M, adding new home data
- BofA maintains underperform ratings on six BDC stocks
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
